The long term antibody response to CMV gB vaccine, in patients requiring liver or renal transplant.

Registry ID

EUCTR2012-002767-95

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

University College London

Start date

2013-04-03

Completion date

2016-06-13

Last update

2026-08-16

Conditions

• Cytomegalovirus.

Summary

The Primary objective is see the antibody levels found months to years after patients entered the randomised placebo-controlled trial of a glycoprotein B vaccine against cytomegalovirus and to have the previous samples retested using new and different methods which have been developed in different labs.

Locations

• , , UK

View on source registry